세계의 의료용 튜브 시장 예측(2025-2030년)

The Global Medical Tubing Market is expected to grow from USD 9.379 billion in 2025 to USD 13.593 billion in 2030, at a CAGR of 7.70%.

Increasing Prevalence of Chronic Diseases

The growing burden of chronic diseases, particularly cardiovascular diseases (CVDs), is a primary driver of the medical tubing market. According to the World Health Organization, CVDs account for 17.9 million deaths annually, representing 31% of global mortality. Risk factors such as tobacco use, unhealthy diets, and physical inactivity elevate the incidence of heart attacks and strokes, necessitating advanced medical interventions. Medical tubing is critical for fluid management, drainage, and drug delivery in cardiac care devices, such as those used to manage irregular heartbeats. The high prevalence of coronary heart disease, exacerbated by obesity, further fuels demand for medical tubing in diagnostic and therapeutic applications, driving market growth.

Aging Global Population

The rapidly aging population, particularly those over 65, is significantly increasing demand for medical tubing. This demographic is more susceptible to chronic conditions, requiring advanced healthcare solutions like catheters and infusion systems. The United Nations projects the global population aged 60 and above to reach 2.1 billion by 2050, with significant growth already evident by 2023. This demographic shift places pressure on healthcare systems, increasing health expenditure and boosting the need for medical tubing in applications ranging from chronic disease management to minimally invasive surgeries.

Government Investments in Healthcare

Favorable government policies and investments in healthcare infrastructure are propelling market growth. Initiatives to enhance healthcare access, particularly in emerging markets, are increasing the adoption of advanced medical devices that rely on medical tubing. For instance, in 2024, India's healthcare budget allocated significant funds to expand tertiary care facilities, driving demand for medical tubing in specialized treatments. Similarly, global efforts to improve healthcare delivery for chronic disease management are supporting market expansion.

Growth in Minimally Invasive Surgeries

The increasing adoption of minimally invasive surgical procedures is a key growth driver. These procedures, which rely heavily on medical tubing for catheters, endoscopes, and drug delivery systems, offer reduced recovery times and lower complication rates. The trend toward minimally invasive techniques, particularly in cardiovascular and oncology treatments, is boosting demand for specialized tubing materials that ensure precision and biocompatibility.

Expansion of the Drug Delivery Industry

The drug delivery sector is experiencing robust growth, driven by innovations in targeted delivery systems. Medical tubing plays a critical role in ensuring precise administration of medications, particularly in chronic disease management. In 2024, key market players introduced advanced tubing solutions for targeted drug delivery, enhancing therapeutic efficacy and patient outcomes, further propelling market growth.

Market Segmentation Analysis

Remote Patient Monitoring

The rise of remote patient monitoring (RPM) is a significant market driver, particularly for chronic disease management. RPM enables tracking of physiological parameters like blood pressure and weight outside clinical settings, reducing emergency visits and hospital stays. In 2023, advancements in RPM devices integrated medical tubing for fluid management and monitoring, improving care for CVD patients. This segment is expected to grow as healthcare providers prioritize cost-effective, patient-centric solutions.

Polymer-Based Tubing

The growing polymer industry is a key contributor to market growth, with materials like silicone, PVC, and polyurethane widely used in medical tubing for their flexibility, durability, and biocompatibility. In 2024, innovations in polymer-based tubing improved performance in applications like catheters and IV lines, driving demand in hospitals and diagnostic centers.

Regional Insights

North America holds the largest market share, driven by high healthcare expenditure, advanced infrastructure, and a high prevalence of chronic diseases. The U.S., with heart disease as a leading cause of death, leads in demand for medical tubing. The Asia-Pacific region is the fastest-growing, fueled by government initiatives to enhance healthcare access and rising chronic disease prevalence in countries like India and China. Europe follows closely, supported by robust healthcare systems and aging populations.

Market Challenges

Challenges include the high cost of advanced polymer materials and stringent regulatory requirements for medical-grade tubing, which can delay product approvals. Additionally, ensuring biocompatibility and durability in diverse applications requires continuous R&D investment, posing barriers for smaller market players.

Conclusion

The medical tubing market is set for robust growth through 2028, driven by the rising prevalence of chronic diseases, an aging population, government healthcare investments, and advancements in minimally invasive surgeries and drug delivery systems. North America and Asia-Pacific are key growth regions, with polymers playing a pivotal role in tubing innovations. However, high costs and regulatory hurdles necessitate strategic innovation to sustain market momentum, ensuring medical tubing meets the evolving needs of the healthcare industry.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Material

• Polyvinyl Chloride
• Polyethylene
• Polypropylene
• Silicone Polymers
• Bioabsorbable Polymers
• Others

By Structure

• Single Lumen
• Multiple Lumen
• Co-Extruded
• Tapered/ Bump Tubing
• Braided Tubing
• Balloon Tubing
• Heat Shrink Tubing

By Application

• Drug Delivery
• Dialysis
• Intravenous (IV)
• Catheters
• Feeding Tubes
• Biopharma lab equipment
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• UK
• Germany
• France
• Others
• Middle East and Africa
• UAE
• Israel
• Saudi Arabia
• Others
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Overview
• 1.2. COVID-19 Scenario
• 1.3. Market Definition
• 1.4. Market Segmentation

2. Research Methodology

• 2.1. Research Data
• 2.2. Assumptions

3. Executive Summary

• 3.1. Research Highlights

4. Market Dynamics

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porters Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. Global Medical Tubing Market Analysis, by Material

• 5.1. Introduction
• 5.2. Polyvinyl Chloride
• 5.3. Polyethylene
• 5.4. Polypropylene
• 5.5. Silicone Polymers
• 5.6. Bioabsorbable Polymers
• 5.7. Others

6. Global Medical Tubing Market Analysis, By Structure

• 6.1. Introduction
• 6.2. Single Lumen
• 6.3. Multiple Lumen
• 6.4. Co-Extruded
• 6.5. Tapered/Bump Tubing
• 6.6. Braided Tubing
• 6.7. Balloon Tubing
• 6.8. Heat Shrink Tubing

7. Global Medical Tubing Market Analysis, By Application

• 7.1. Introduction
• 7.2. Drug Delivery
• 7.3. Dialysis
• 7.4. Intravenous (IV)
• 7.5. Catheters
• 7.6. Feeding Tubes
• 7.7. Biopharma lab equipment
• 7.8. Others

8. Global Medical Tubing Market Analysis, by Geography

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. UK
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Others
• 8.5. Middle East and Africa
  • 8.5.1. United Arab Emirates
  • 8.5.2. Israel
  • 8.5.3. Saudi Arabia
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. Australia
  • 8.6.5. South Korea
  • 8.6.6. Indonesia
  • 8.6.7. Thailand
  • 8.6.8. Taiwan
  • 8.6.9. Others

9. Competitive Environment and Analysis

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. Company Profiles

• 10.1. Compagnie de Saint-Gobain S.A.
• 10.2. Freudenberg Medical
• 10.3. W. L. Gore & Associates, Inc.
• 10.4. The Lubrizol Corporation
• 10.5. Nordson Corporation

106. TE Connectivity Ltd.

• 10.7. Elkem ASA
• 10.8 Trelleborg AB